Too often the industry overfits on 100% coverage rather than cost-effective risk-informed defenses.
It's okay to assess a technique as low risk and to not have specific coverage.
MITRE's biases don't need to be your biases.
Too often the industry overfits on 100% coverage rather than cost-effective risk-informed defenses.
It's okay to assess a technique as low risk and to not have specific coverage.
MITRE's biases don't need to be your biases.